etinilestradiol/drospirenona diario mylan pharmaceuticals 0,02mg/3mg comprimidos rec
etinilestradiol/drospirenona diario mylan pharmaceuticals 0,02mg/3mg comprimidos rec
etinilestradiol/drospirenona diario mylan pharmaceuticals 0,03mg/3mg comprimidos rec
etinilestradiol/drospirenona diario mylan pharmaceuticals 0,03mg/3mg comprimidos rec
etinilestradiol/drospirenona mylan pharmaceuticals 0,02mg/3mg comprimidos recubierto
etinilestradiol/drospirenona mylan pharmaceuticals 0,02mg/3mg comprimidos recubierto
etinilestradiol/drospirenona mylan pharmaceuticals 0,03mg/3mg comprimidos recubierto
etinilestradiol/drospirenona mylan pharmaceuticals 0,03mg/3mg comprimidos recubierto
ىاز
bayer israel ltd - drospirenone 3 mg; ethinylestradiol 0.02 mg - film coated tablets - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).
etinilestradiol/drospirenona diario cinfalab 0,03 mg/3 mg comprimidos recubiertos co